The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Paetzold Mary E since 2008.
The trader's CIK number is 1247904.
At the time of the last reporting, Paetzold Mary E was the Director of Immunomedics Inc. (stock ticker symbol IMMU).
Also see all insider trading activities at Immunomedics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | IMMU | 0 | $0 | 15,000 | $44,670 | 29,469 | $29,400 |
| 2015 | IMMU | 0 | $0 | 4,677 | $21,532 | 30,664 | $34,027 |
| 2014 | IMMU | 0 | $0 | 10,000 | $47,050 | 19,554 | $23,800 |
| 2013 | IMMU | 0 | $0 | 0 | $0 | 14,950 | $0 |
| 2012 | IMMU | 0 | $0 | 0 | $0 | 5,000 | $0 |
| 2011 | IMMU | 0 | $0 | 0 | $0 | 5,000 | $0 |
| 2010 | IMMU | 0 | $0 | 0 | $0 | 5,000 | $0 |
| 2009 | IMMU | 0 | $0 | 0 | $0 | 5,000 | $0 |
| 2008 | IMMU | 0 | $0 | 0 | $0 | 5,000 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-12-02 | IMMU | Option Ex | 14,469 | .00 | 0 |
| 2016-08-23 | IMMU | Sale | 15,000 | 2.98 | 44,670 |
| 2016-08-23 | IMMU | Option Ex | 15,000 | 1.96 | 29,400 |
| 2015-12-01 | IMMU | Option Ex | 20,664 | .80 | 16,427 |
| 2015-06-09 | IMMU | Option Ex | 10,000 | 1.76 | 17,600 |
| 2015-06-09 | IMMU | Sale | 4,677 | 4.60 | 21,532 |
| 2014-12-11 | IMMU | Option Ex | 10,000 | 2.38 | 23,800 |
| 2014-12-11 | IMMU | Sale | 10,000 | 4.71 | 47,050 |
| 2014-12-03 | IMMU | Option Ex | 9,554 | .00 | 0 |
| 2013-12-04 | IMMU | Option Ex | 14,950 | .00 | 0 |
| 2012-12-05 | IMMU | Option Ex | 5,000 | .00 | 0 |
| 2011-12-07 | IMMU | Option Ex | 5,000 | .00 | 0 |
| 2010-12-01 | IMMU | Option Ex | 5,000 | .00 | 0 |
| 2009-12-02 | IMMU | Option Ex | 5,000 | .00 | 0 |
| 2008-12-03 | IMMU | Option Ex | 5,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Paetzold Mary E (Director of Immunomedics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.